Micha JP - Search Results

1

Paget's disease of the vulva: a clinicopathologic institutional review.

Mendivil AA, Abaid L, Epstein HD, Rettenmaier MA, Brown JV 3rd, Micha JP, Wabe MA, Goldstein BH. Mendivil AA, et al. Among authors: micha jp. Int J Clin Oncol. 2012 Dec;17(6):569-74. doi: 10.1007/s10147-011-0325-0. Epub 2011 Oct 1. Int J Clin Oncol. 2012. PMID: 21964675

2

Whole-abdominal radiotherapy for patients with minimal residual epithelial ovarian cancer.

Kucera PR, Berman ML, Treadwell P, Sheets EE, Micha JP, Rettenmaier MA, Colman M, DiSaia PJ. Kucera PR, et al. Among authors: micha jp. Gynecol Oncol. 1990 Mar;36(3):338-42. doi: 10.1016/0090-8258(90)90138-b. Gynecol Oncol. 1990. PMID: 2318442

3

Radical hysterectomy and tailored postoperative radiation therapy in the management of bulky stage 1B cervical cancer.

Rettenmaier MA, Casanova DM, Micha JP, Moran MF, Ramsanghani NS, Syed NA, Puthawala A, DiSaia PJ. Rettenmaier MA, et al. Among authors: micha jp. Cancer. 1989 Jun 1;63(11):2220-3. doi: 10.1002/1097-0142(19890601)63:11<2220::aid-cncr2820631127>3.0.co;2-m. Cancer. 1989. PMID: 2720571

4

Ovarian epithelial tumors of low malignant potential.

Chien RT, Rettenmaier MA, Micha JP, DiSaia PJ. Chien RT, et al. Among authors: micha jp. Surg Gynecol Obstet. 1989 Aug;169(2):143-6. Surg Gynecol Obstet. 1989. PMID: 2756462

5

Accurate laboratory predictions of the clinical response of patients with advanced ovarian cancer to treatment with cyclophosphamide, doxorubicin, and cisplatin.

Stratton JA, Kucera PR, Rettenmaier MA, Dobashi K, Micha JP, Braly PS, Berman ML, DiSaia PJ. Stratton JA, et al. Among authors: micha jp. Gynecol Oncol. 1986 Nov;25(3):302-10. doi: 10.1016/0090-8258(86)90081-8. Gynecol Oncol. 1986. PMID: 3781341

6

A simplified method for right atrial catheter insertion.

Rettenmaier MA, Micha JP, Kucera PR, Berman ML, Disaia PJ. Rettenmaier MA, et al. Among authors: micha jp. Gynecol Oncol. 1985 Jun;21(2):207-10. doi: 10.1016/0090-8258(85)90253-7. Gynecol Oncol. 1985. PMID: 3988133

7

Action of 2-beta-D-ribofuranosylthiazole-4-carboxamide (tiazofurin) against untreated human ovarian cancers in the murine xenograft assay.

Micha JP, Kucera PR, Preve CU, Rettenmaier MA, Stratton JA, DiSaia PJ. Micha JP, et al. Gynecol Oncol. 1985 Jul;21(3):351-5. doi: 10.1016/0090-8258(85)90273-2. Gynecol Oncol. 1985. PMID: 4007612

8

The subrenal capsule tumor implant assay as a predictor of clinical response to chemotherapy: 3 years of experience.

Stratton JA, Kucera PR, Micha JP, Rettenmaier MA, Braly PS, Berman ML, DiSaia PJ. Stratton JA, et al. Among authors: micha jp. Gynecol Oncol. 1984 Nov;19(3):336-47. doi: 10.1016/0090-8258(84)90201-4. Gynecol Oncol. 1984. PMID: 6500376

9

Chemosensitivity testing of nonsolid tumors by the subrenal-capsule implant assay.

Stratton JA, Micha JP, Rettenmaier MA, Braley PS, DiSaia PJ. Stratton JA, et al. Among authors: micha jp. Gynecol Oncol. 1984 Feb;17(2):185-8. doi: 10.1016/0090-8258(84)90075-1. Gynecol Oncol. 1984. PMID: 6584388

10

Three-hour paclitaxel infusion and carboplatin is an effective outpatient treatment for stage III epithelial ovarian cancer.

Brown JV, Rettenmaier MA, Dillman RA, Birk CL, Culkin K, Micha JP. Brown JV, et al. Among authors: micha jp. Gynecol Oncol. 1998 Feb;68(2):166-8. doi: 10.1006/gyno.1997.4916. Gynecol Oncol. 1998. PMID: 9514805

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

111 results

Search Page